<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250411001431&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250411001431&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Fri, 11 Apr 2025 04:14:32 +0000</lastbuilddate>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Long Noncoding RNA &lt;em>;MIR181A1HG&lt;/em>; Takes a Proinflammatory Driver's Seat in Atherosclerosis by Hijacking FOXP1</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40208929/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Apr 11;136(8):884-886. doi: 10.1161/CIRCRESAHA.125.326366. Epub 2025 Apr 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40208929/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40208929</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.125.326366>10.1161/CIRCRESAHA.125.326366</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40208929</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>James A Oo</dc:creator>
<dc:creator>Timothy Warwick</dc:creator>
<dc:creator>Matthias S Leisegang</dc:creator>
<dc:date>2025-04-10</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Long Noncoding RNA &lt;em>;MIR181A1HG&lt;/em>; Takes a Proinflammatory Driver's Seat in Atherosclerosis by Hijacking FOXP1</dc:title>
<dc:identifier>pmid:40208929</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.125.326366</dc:identifier>
</item>
<item>
<title>&lt;em>;TMEM&lt;/em>;-ing the Tide: Gene Therapy Holds Promise for ARVC5</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40208928/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Apr 11;136(8):845-847. doi: 10.1161/CIRCRESAHA.125.326367. Epub 2025 Apr 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40208928/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40208928</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.125.326367>10.1161/CIRCRESAHA.125.326367</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40208928</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Sandra Ratnavadivel</dc:creator>
<dc:creator>Matthew W Ellis</dc:creator>
<dc:creator>Farah Sheikh</dc:creator>
<dc:date>2025-04-10</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>&lt;em>;TMEM&lt;/em>;-ing the Tide: Gene Therapy Holds Promise for ARVC5</dc:title>
<dc:identifier>pmid:40208928</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.125.326367</dc:identifier>
</item>
<item>
<title>Nuclear Receptors in Platelet Activation and Thrombosis in Hypercholesterolemia</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40208927/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Apr 11;136(8):827-829. doi: 10.1161/CIRCRESAHA.125.326364. Epub 2025 Apr 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40208927/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40208927</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.125.326364>10.1161/CIRCRESAHA.125.326364</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40208927</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Yanki Yarman</dc:creator>
<dc:creator>Xuefei Zhao</dc:creator>
<dc:creator>Peisong Ma</dc:creator>
<dc:date>2025-04-10</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Nuclear Receptors in Platelet Activation and Thrombosis in Hypercholesterolemia</dc:title>
<dc:identifier>pmid:40208927</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.125.326364</dc:identifier>
</item>
<item>
<title>Gut Instincts: The Gut Microbiome-Cardiovascular Inflammation Axis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40208926/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Apr 11;136(8):806-808. doi: 10.1161/CIRCRESAHA.125.326363. Epub 2025 Apr 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40208926/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40208926</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.125.326363>10.1161/CIRCRESAHA.125.326363</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40208926</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Jessie M Dalman</dc:creator>
<dc:creator>Emma R Blaustein</dc:creator>
<dc:creator>Coen van Solingen</dc:creator>
<dc:date>2025-04-10</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Gut Instincts: The Gut Microbiome-Cardiovascular Inflammation Axis</dc:title>
<dc:identifier>pmid:40208926</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.125.326363</dc:identifier>
</item>
<item>
<title>Pathways and Molecular Mechanisms Governing LDL Receptor Regulation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40208925/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>Clearance of circulating plasma LDL (low-density lipoprotein) cholesterol by the liver requires hepatic LDLR (low-density lipoprotein receptor). Complete absence of functional LDLR manifests in severe hypercholesterolemia and premature atherosclerotic cardiovascular disease. Since the discovery of the LDLR 50 years ago by Brown and Goldstein, all approved lipid-lowering medications have been aimed at increasing the abundance and availability of LDLR on the surface of hepatocytes to promote the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Apr 11;136(8):902-919. doi: 10.1161/CIRCRESAHA.124.323578. Epub 2025 Apr 10.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Clearance of circulating plasma LDL (low-density lipoprotein) cholesterol by the liver requires hepatic LDLR (low-density lipoprotein receptor). Complete absence of functional LDLR manifests in severe hypercholesterolemia and premature atherosclerotic cardiovascular disease. Since the discovery of the LDLR 50 years ago by Brown and Goldstein, all approved lipid-lowering medications have been aimed at increasing the abundance and availability of LDLR on the surface of hepatocytes to promote the removal of LDL particles from the circulation. As such a critical regulator of circulating and cellular cholesterol, it is not surprising that LDLR activity is tightly regulated. Despite over half a century's worth of study, there are still many facets of LDLR biology that remain unexplored. This review will focus on pathways that regulate the LDLR and emerging concepts of LDLR biology.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40208925/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40208925</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.323578>10.1161/CIRCRESAHA.124.323578</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40208925</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Heidi M Schmidt</dc:creator>
<dc:creator>Kelsey E Jarrett</dc:creator>
<dc:creator>Thomas Q de Aguiar Vallim</dc:creator>
<dc:creator>Elizabeth J Tarling</dc:creator>
<dc:date>2025-04-10</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Pathways and Molecular Mechanisms Governing LDL Receptor Regulation</dc:title>
<dc:identifier>pmid:40208925</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.323578</dc:identifier>
</item>
<item>
<title>Meet the First Authors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40208924/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Apr 11;136(8):803-805. doi: 10.1161/RES.0000000000000713. Epub 2025 Apr 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40208924/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40208924</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000713>10.1161/RES.0000000000000713</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40208924</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:date>2025-04-10</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Meet the First Authors</dc:title>
<dc:identifier>pmid:40208924</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000713</dc:identifier>
</item>
<item>
<title>Patient-prosthesis mismatch after aortic valve replacement: one size does not fit all</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40208249/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 10:ehaf200. doi: 10.1093/eurheartj/ehaf200. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40208249/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40208249</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf200>10.1093/eurheartj/ehaf200</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40208249</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Francesco Zito</dc:creator>
<dc:creator>Reda Rhellab</dc:creator>
<dc:creator>Adine R de Keijzer</dc:creator>
<dc:date>2025-04-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Patient-prosthesis mismatch after aortic valve replacement: one size does not fit all</dc:title>
<dc:identifier>pmid:40208249</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf200</dc:identifier>
</item>
<item>
<title>Expanding CAD assessment beyond coronary arteries: can body composition offer valuable insights?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40208238/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 10:ehaf143. doi: 10.1093/eurheartj/ehaf143. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40208238/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40208238</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf143>10.1093/eurheartj/ehaf143</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40208238</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Mouaz Al-Mallah</dc:creator>
<dc:creator>Mahmoud Al Rifai</dc:creator>
<dc:date>2025-04-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Expanding CAD assessment beyond coronary arteries: can body composition offer valuable insights?</dc:title>
<dc:identifier>pmid:40208238</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf143</dc:identifier>
</item>
<item>
<title>Exercise-based cardiac rehabilitation: the importance of home-based approaches</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40208237/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 10:ehaf202. doi: 10.1093/eurheartj/ehaf202. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40208237/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40208237</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf202>10.1093/eurheartj/ehaf202</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40208237</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Rod S Taylor</dc:creator>
<dc:creator>Amy Blakemore</dc:creator>
<dc:date>2025-04-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Exercise-based cardiac rehabilitation: the importance of home-based approaches</dc:title>
<dc:identifier>pmid:40208237</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf202</dc:identifier>
</item>
<item>
<title>Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention†</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40208236/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Among statin-treated patients undergoing PCI, residual inflammation but not cholesterol risk was associated with an increased risk of MACE during follow-up.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 10:ehaf196. doi: 10.1093/eurheartj/ehaf196. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Elevated LDL-cholesterol levels and inflammation, as assessed by high-sensitivity C-reactive protein, correlate with cardiovascular risk. However, data on the relative impact of residual LDL-cholesterol and inflammatory risk among statin-treated patients undergoing percutaneous coronary intervention (PCI) is lacking. Hence, this study aimed to investigate the impact of residual cholesterol/inflammatory risk in patients on statin therapy undergoing PCI.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: From 2012 to 2022, patients at a tertiary centre undergoing PCI were analysed. Patients were stratified according to LDL-cholesterol (≥70 vs &lt;70 mg/dL) and high-sensitivity C-reactive protein (≥2 vs &lt;2 mg/L) levels: no residual cholesterol or inflammatory risk, residual cholesterol risk, residual inflammatory risk, and combined residual cholesterol and inflammatory risk. Patients presenting with acute myocardial infarction, cancer, no statin treatment at admission, or high-sensitivity C-reactive protein levels >;10 mg/L were excluded. The primary endpoint was major adverse cardiovascular events (MACEs), defined as the composite of all-cause mortality, spontaneous myocardial infarction, and stroke 1 year after the index PCI.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 15 494 patients were included. After 1-year follow-up, individuals with isolated residual inflammatory risk had the highest MACE rate (5.1%), followed by patients with combined cholesterol and inflammatory risk, no residual risk, and isolated residual cholesterol risk. After multivariable Cox regression analysis, patients with residual inflammatory risk had a 1.8-fold higher risk for MACE (adjusted hazard ratio: 1.78, 95% confidence interval 1.36-2.33, P &lt; .001) compared with those with no residual cholesterol or inflammatory risk. This was similar in patients with combined residual cholesterol and inflammatory risk (adjusted hazard ratio: 1.56, 95% confidence interval 1.19-2.04, P = 0.001). Of note, no independent association of isolated residual cholesterol risk (adjusted hazard ratio: 1.01, 95% confidence interval .76-1.35, P-value = .920) with MACE was noted (P-trend across all groups &lt;.001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Among statin-treated patients undergoing PCI, residual inflammation but not cholesterol risk was associated with an increased risk of MACE during follow-up.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40208236/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40208236</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf196>10.1093/eurheartj/ehaf196</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40208236</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Benjamin Bay</dc:creator>
<dc:creator>Richard Tanner</dc:creator>
<dc:creator>Michael Gao</dc:creator>
<dc:creator>Angelo Oliva</dc:creator>
<dc:creator>Samantha Sartori</dc:creator>
<dc:creator>Birgit Vogel</dc:creator>
<dc:creator>Mauro Gitto</dc:creator>
<dc:creator>Kenneth F Smith</dc:creator>
<dc:creator>Francesca Maria Di Muro</dc:creator>
<dc:creator>Amit Hooda</dc:creator>
<dc:creator>Joseph Sweeny</dc:creator>
<dc:creator>Parasuram Krishnamoorthy</dc:creator>
<dc:creator>Pedro Moreno</dc:creator>
<dc:creator>Prakash Krishnan</dc:creator>
<dc:creator>George Dangas</dc:creator>
<dc:creator>Annapoorna Kini</dc:creator>
<dc:creator>Samin K Sharma</dc:creator>
<dc:creator>Roxana Mehran</dc:creator>
<dc:date>2025-04-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention†</dc:title>
<dc:identifier>pmid:40208236</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf196</dc:identifier>
</item>
<item>
<title>Gain-of-function enhancer variant near KCNB1 causes familial ST-depression syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40208226/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: A gain-of-function enhancer variant creates a hyperactive regulatory locus that interacts with the KCNB1 promoter and causes FSTD. This is the first time that KCNB1 has been implicated in human cardiac electrophysiology and arrhythmogenesis.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 10:ehaf213. doi: 10.1093/eurheartj/ehaf213. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Familial ST-depression syndrome (FSTD) is a recently identified inherited cardiac disease associated with arrhythmias and systolic dysfunction. The underlying genetic aetiology has remained elusive. This study aimed at finding the causative variant.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A total of 67 FSTD patients (20 families) were studied. Linkage analysis and whole-genome sequencing (WGS) were initially performed. An identified non-coding variant was functionally characterized in AC16 human cardiomyocytes, muscle tissue, and human myocardium. In silico analyses, luciferase and dCas9-activator/repressor assays, protein-DNA experiments, chromosome conformation capture (4C), and RNA sequencing were also performed.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The electrocardiographic (ECG) phenotype was inherited in an autosomal dominant manner in all families. Linkage analysis revealed a single peak on chromosome 20, and WGS identified a single, rare, non-coding variant located 18 kb downstream of KCNB1 on chromosome 20 in all affected individuals. Perfect co-segregation with the ECG phenotype was observed together with full penetrance in all families. The variant creates a MEF2-binding site and presence of the variant allele or MEF2 co-expression enhanced transcriptional activity. dCas9-activator/repressor assays showed that KCNB1 was the only gene consistently regulated by the locus and 4C experiments in AC16 cells and human muscle tissue confirmed the locus-KCNB1 promoter interaction. Expression analysis in human endocardial tissue did not document any change in gene expression likely explained by expressional heterogeneity.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: A gain-of-function enhancer variant creates a hyperactive regulatory locus that interacts with the KCNB1 promoter and causes FSTD. This is the first time that KCNB1 has been implicated in human cardiac electrophysiology and arrhythmogenesis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40208226/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40208226</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf213>10.1093/eurheartj/ehaf213</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40208226</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Alex Hørby Christensen</dc:creator>
<dc:creator>Gang Pan</dc:creator>
<dc:creator>Rasmus L Marvig</dc:creator>
<dc:creator>Francisco German Rodriguez Gonzalez</dc:creator>
<dc:creator>Christoffer Rasmus Vissing</dc:creator>
<dc:creator>Elvira Silajdzija</dc:creator>
<dc:creator>Rasmus Frosted</dc:creator>
<dc:creator>Etsehiwot Girum Girma</dc:creator>
<dc:creator>Migle Gabrielaite</dc:creator>
<dc:creator>Henrik Kjærulf Jensen</dc:creator>
<dc:creator>Kasper Rossing</dc:creator>
<dc:creator>Finn Lund Henriksen</dc:creator>
<dc:creator>Niels Christian Foldager Sandgaard</dc:creator>
<dc:creator>Gustav Ahlberg</dc:creator>
<dc:creator>Jonas Ghouse</dc:creator>
<dc:creator>Pia Rengtved Lundegaard</dc:creator>
<dc:creator>Joachim Weischenfeldt</dc:creator>
<dc:creator>Claes Wadelius</dc:creator>
<dc:creator>Henning Bundgaard</dc:creator>
<dc:date>2025-04-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Gain-of-function enhancer variant near KCNB1 causes familial ST-depression syndrome</dc:title>
<dc:identifier>pmid:40208226</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf213</dc:identifier>
</item>
<item>
<title>The American College of Cardiology: Never Wavering in the Pursuit of Excellence</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40208162/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Apr 2:S0735-1097(25)05876-0. doi: 10.1016/j.jacc.2025.03.480. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40208162/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40208162</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.03.480>10.1016/j.jacc.2025.03.480</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40208162</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Cathleen Biga</dc:creator>
<dc:date>2025-04-10</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>The American College of Cardiology: Never Wavering in the Pursuit of Excellence</dc:title>
<dc:identifier>pmid:40208162</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.03.480</dc:identifier>
</item>
<item>
<title>High-Throughput Echocardiography-Guided Induction of Myocardial Ischemia/Reperfusion in Mice</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40207377/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Echocardiography-guided induction of myocardial IR enables high-throughput induction of myocardial IR injury with precise echocardiographic definition of the occlusion level and immediate evaluation of cardiac function during ischemia. The method provides a more clinically relevant assessment of IR sequelae and offers notable animal welfare advantages by eliminating the need for ventilation and thoracotomy, thereby mitigating potential surgery-related confounders.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Apr 10. doi: 10.1161/CIRCRESAHA.125.326156. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Mouse models of myocardial ischemia with subsequent heart failure are common approaches to examine heart failure pathology and possible treatment strategies. We sought to establish a high-throughput approach for echocardiography-guided induction of myocardial ischemia/reperfusion (IR) in mice.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: After visualization of the left coronary artery with high-resolution ultrasound imaging and echocardiographic definition of the level of coronary occlusion, the left anterior descending artery was temporarily occluded with 2 micromanipulator-controlled needles. Functional and molecular changes were assessed and compared with commonly performed surgical techniques.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Echocardiography-guided induction of myocardial IR enabled standardized induction of myocardial IR injury with subsequent left ventricular remodeling. Incorporation of various quality control measures throughout the procedure ensured a high success rate and the absence of relevant postinterventional mortality in experienced hands. Compared with surgical approaches, echocardiography-guided induction of myocardial IR showed a quicker recovery time and induced a less pronounced inflammatory response characterized by decreased local and systemic neutrophil counts. Notably, infarct size and subsequent post-myocardial infarction cardiac dysfunction were comparable between methods. The novel procedure was successfully implemented at different academic institutions with imaging expertise and demonstrated high interinstitutional reproducibility.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Echocardiography-guided induction of myocardial IR enables high-throughput induction of myocardial IR injury with precise echocardiographic definition of the occlusion level and immediate evaluation of cardiac function during ischemia. The method provides a more clinically relevant assessment of IR sequelae and offers notable animal welfare advantages by eliminating the need for ventilation and thoracotomy, thereby mitigating potential surgery-related confounders.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40207377/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40207377</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.125.326156>10.1161/CIRCRESAHA.125.326156</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40207377</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Florian Sicklinger</dc:creator>
<dc:creator>Niklas Hartmann</dc:creator>
<dc:creator>Attila Kovacs</dc:creator>
<dc:creator>Carla Weinheimer</dc:creator>
<dc:creator>Jess Nigro</dc:creator>
<dc:creator>Tobias Thiemann</dc:creator>
<dc:creator>Junedh Amrute</dc:creator>
<dc:creator>David Schumacher</dc:creator>
<dc:creator>Moritz Kornardt</dc:creator>
<dc:creator>Laura M Wienecke</dc:creator>
<dc:creator>Lennart Rompel</dc:creator>
<dc:creator>Johannes Fischer</dc:creator>
<dc:creator>John Bachman</dc:creator>
<dc:creator>Olivia Bedard</dc:creator>
<dc:creator>Shibali Das</dc:creator>
<dc:creator>Tim C Kuhn</dc:creator>
<dc:creator>Mirko Völkers</dc:creator>
<dc:creator>Ralf P Brandes</dc:creator>
<dc:creator>Rafael Kramann</dc:creator>
<dc:creator>Nadia Rosenthal</dc:creator>
<dc:creator>Norbert Frey</dc:creator>
<dc:creator>Kory J Lavine</dc:creator>
<dc:creator>Florian Leuschner</dc:creator>
<dc:date>2025-04-10</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>High-Throughput Echocardiography-Guided Induction of Myocardial Ischemia/Reperfusion in Mice</dc:title>
<dc:identifier>pmid:40207377</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.125.326156</dc:identifier>
</item>
<item>
<title>Sedentary Behavior and Light-Intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40207357/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>The Physical Activity Guidelines for Americans supports sitting less and moving more. Growing evidence suggests that a waking behavior profile with less sedentary behavior and more light-intensity physical activity is associated with more favorable cardiovascular health. Remarkably, little is known about how these behaviors relate to cardiovascular health during pregnancy. The purpose of this American Heart Association science advisory is to describe the existing evidence on device-measured...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 10. doi: 10.1161/CIR.0000000000001316. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The Physical Activity Guidelines for Americans supports sitting less and moving more. Growing evidence suggests that a waking behavior profile with less sedentary behavior and more light-intensity physical activity is associated with more favorable cardiovascular health. Remarkably, little is known about how these behaviors relate to cardiovascular health during pregnancy. The purpose of this American Heart Association science advisory is to describe the existing evidence on device-measured sedentary behavior and light-intensity physical activity in relation to cardiovascular health during pregnancy and to make specific calls to action for future research to improve health outcomes and to promote health equity. Outcomes included adverse pregnancy outcomes associated with increased risk of cardiovascular disease and the American Heart Association's Life's Essential 8 health factor components (blood pressure, lipids, glucose, and gestational weight gain). Findings from observational studies are mixed, with preliminary evidence demonstrating an association between high sedentary behavior and increased risk of hypertensive disorders of pregnancy, shorter gestational age at delivery, low or high birth weight, and elevated maternal blood pressure, lipids, glucose, and gestational weight gain. Findings for light-intensity physical activity are limited by fewer studies and are less compelling. Experimental evidence evaluating the impact of decreasing sedentary behavior or increasing light-intensity physical activity on pregnancy cardiovascular health is weak. Future observational studies with rigorous longitudinal designs and larger, diverse samples are needed to characterize associations and to inform the design of adequately powered randomized controlled trials testing the impact of decreasing sedentary behavior and increasing light-intensity physical activity on cardiovascular health during pregnancy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40207357/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40207357</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001316>10.1161/CIR.0000000000001316</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40207357</guid>
<pubDate>Thu, 10 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Kara M Whitaker</dc:creator>
<dc:creator>Bethany Barone Gibbs</dc:creator>
<dc:creator>Marie-France Hivert</dc:creator>
<dc:creator>Nour Makarem</dc:creator>
<dc:creator>Elizabeth Moxley</dc:creator>
<dc:creator>Jason Vaught</dc:creator>
<dc:creator>Kelly R Evenson</dc:creator>
<dc:creator>American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; and Council on Cardiovascular Surgery and Anesthesia</dc:creator>
<dc:date>2025-04-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Sedentary Behavior and Light-Intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association</dc:title>
<dc:identifier>pmid:40207357</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001316</dc:identifier>
</item>
<item>
<title>Reply: Strengthening Temperature-Stroke Associations: Methodologic Considerations</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40204383/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Apr 15;85(14):1522. doi: 10.1016/j.jacc.2025.01.036.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40204383/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40204383</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.01.036>10.1016/j.jacc.2025.01.036</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40204383</guid>
<pubDate>Wed, 09 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Lingzhi Chu</dc:creator>
<dc:creator>Xiaomei Ma</dc:creator>
<dc:creator>Kai Chen</dc:creator>
<dc:date>2025-04-09</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: Strengthening Temperature-Stroke Associations: Methodologic Considerations</dc:title>
<dc:identifier>pmid:40204383</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.01.036</dc:identifier>
</item>
<item>
<title>Strengthening Temperature-Stroke Associations: Methodologic Considerations</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40204382/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Apr 15;85(14):1521. doi: 10.1016/j.jacc.2024.11.054.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40204382/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40204382</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.11.054>10.1016/j.jacc.2024.11.054</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40204382</guid>
<pubDate>Wed, 09 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Jian Huang</dc:creator>
<dc:date>2025-04-09</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Strengthening Temperature-Stroke Associations: Methodologic Considerations</dc:title>
<dc:identifier>pmid:40204382</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.11.054</dc:identifier>
</item>
<item>
<title>Articulating the JACC Journals' Direction in Times of Global Change</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40204381/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Apr 15;85(14):1515-1516. doi: 10.1016/j.jacc.2025.02.006. Epub 2025 Feb 12.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40204381/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40204381</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.02.006>10.1016/j.jacc.2025.02.006</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40204381</guid>
<pubDate>Wed, 09 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Harlan M Krumholz</dc:creator>
<dc:creator>Biykem Bozkurt</dc:creator>
<dc:creator>Y Chandrashekhar</dc:creator>
<dc:creator>Bonnie Ky</dc:creator>
<dc:creator>Douglas L Mann</dc:creator>
<dc:creator>David J Moliterno</dc:creator>
<dc:creator>Kalyanam Shivkumar</dc:creator>
<dc:creator>Candice K Silversides</dc:creator>
<dc:creator>Gilbert H L Tang</dc:creator>
<dc:creator>Jian'an Wang</dc:creator>
<dc:date>2025-04-09</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Articulating the JACC Journals' Direction in Times of Global Change</dc:title>
<dc:identifier>pmid:40204381</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.02.006</dc:identifier>
</item>
<item>
<title>Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Is Enthusiasm Exceeding the Evidence?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40204380/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Apr 15;85(14):1511-1514. doi: 10.1016/j.jacc.2025.03.002.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40204380/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40204380</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.03.002>10.1016/j.jacc.2025.03.002</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40204380</guid>
<pubDate>Wed, 09 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Sanjay Kaul</dc:creator>
<dc:date>2025-04-09</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Is Enthusiasm Exceeding the Evidence?</dc:title>
<dc:identifier>pmid:40204380</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.03.002</dc:identifier>
</item>
<item>
<title>One Step Closer to Unlocking Preeclampsia Prevention</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40204379/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Apr 15;85(14):1501-1503. doi: 10.1016/j.jacc.2025.03.455.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40204379/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40204379</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.03.455>10.1016/j.jacc.2025.03.455</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40204379</guid>
<pubDate>Wed, 09 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Christina M Ackerman-Banks</dc:creator>
<dc:creator>Erica S Spatz</dc:creator>
<dc:creator>Heather S Lipkind</dc:creator>
<dc:date>2025-04-09</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>One Step Closer to Unlocking Preeclampsia Prevention</dc:title>
<dc:identifier>pmid:40204379</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.03.455</dc:identifier>
</item>
<item>
<title>Genetic Risk and First-Trimester Cardiovascular Health Predict Hypertensive Disorders of Pregnancy in Nulliparous Women</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40204378/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Lower genetic risk and higher first-trimester CVH were independently and additively associated with lower risk of developing HDPs in nulliparous individuals. Favorable CVH in early pregnancy may mitigate high genetic risk for HDP.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Apr 15;85(14):1488-1500. doi: 10.1016/j.jacc.2025.02.015.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Hypertensive disorders of pregnancy (HDPs) (preeclampsia/eclampsia and gestational hypertension) are a leading cause of maternal and perinatal morbidity and mortality and are associated with long-term maternal cardiovascular disease. High genetic risk and poor cardiovascular health (CVH) are each associated with HDPs, but whether genetic risk for HDP is modified by CVH status in early pregnancy is unknown.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: In this study, the authors sought to test the independent and joint associations of genetic risk and first-trimester CVH with development of HDP.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We examined genotyped participants from the nuMoM2b (Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be), a prospective observational cohort that enrolled nulliparous individuals with singleton pregnancies from 2010 to 2013 at 8 U.S. clinical sites. Genetic risk was calculated according to a validated genetic risk score for HDP. A first-trimester CVH score was closely adapted from the American Heart Association Life's Essential 8 model. Genetic risk and CVH were each categorized as low (bottom quintile), intermediate (quintile 2-4), or high (top quintile). The primary outcome was development of HDP. Multivariable-adjusted logistic regression was used to test the independent and joint associations of genetic risk and CVH with development of HDPs.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among 7,499 participants (mean age 27.0 years), the median first-trimester CVH score was 77.1 (Q1-Q3: 67.1-85.7). Overall, 1,032 participants (13.8%) developed an HDP (487 [6.5%] preeclampsia, 545 [7.3%] gestational hypertension). Genetic risk and CVH were each independently and additively associated with HDP (high vs low genetic risk: adjusted OR [aOR]: 2.21 [95% CI: 1.78-2.77; P &lt; 0.001]; low vs high CVH: aOR: 2.92 [95% CI: 2.28-3.74; P &lt; 0.001]). There was no significant interaction between genetic risk and CVH regarding risk of HDPs (P<sub>interaction</sub> >; 0.05). HDP incidence ranged from 4.5% (low genetic risk, high CVH) to 25.7% (high genetic risk, low CVH). Compared with low CVH, high CVH was associated with 53%-74% lower risk of HDP across genetic risk strata. Findings were consistent when examining preeclampsia/eclampsia and gestational hypertension separately.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Lower genetic risk and higher first-trimester CVH were independently and additively associated with lower risk of developing HDPs in nulliparous individuals. Favorable CVH in early pregnancy may mitigate high genetic risk for HDP.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40204378/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40204378</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.02.015>10.1016/j.jacc.2025.02.015</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40204378</guid>
<pubDate>Wed, 09 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Vineetha Mathew</dc:creator>
<dc:creator>Raiyan R Khan</dc:creator>
<dc:creator>Amanda R Jowell</dc:creator>
<dc:creator>Qi Yan</dc:creator>
<dc:creator>Itsik Pe'er</dc:creator>
<dc:creator>Buu Truong</dc:creator>
<dc:creator>Pradeep Natarajan</dc:creator>
<dc:creator>Lynn M Yee</dc:creator>
<dc:creator>Sadiya S Khan</dc:creator>
<dc:creator>Garima Sharma</dc:creator>
<dc:creator>Aniruddh P Patel</dc:creator>
<dc:creator>So Mi Jemma Cho</dc:creator>
<dc:creator>Maria A Pabon</dc:creator>
<dc:creator>Rebecca B McNeil</dc:creator>
<dc:creator>Jillyn Spencer</dc:creator>
<dc:creator>Robert M Silver</dc:creator>
<dc:creator>Lisa D Levine</dc:creator>
<dc:creator>William A Grobman</dc:creator>
<dc:creator>Janet M Catov</dc:creator>
<dc:creator>David M Haas</dc:creator>
<dc:creator>Michael C Honigberg</dc:creator>
<dc:date>2025-04-09</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Genetic Risk and First-Trimester Cardiovascular Health Predict Hypertensive Disorders of Pregnancy in Nulliparous Women</dc:title>
<dc:identifier>pmid:40204378</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.02.015</dc:identifier>
</item>
<item>
<title>Troponin Testing for Cardiovascular Primary Prevention Decision Making?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40204377/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250411001431&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Apr 15;85(14):1485-1487. doi: 10.1016/j.jacc.2025.02.026.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40204377/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250411001431&v=2.18.0.post9+e462414">40204377</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.02.026>10.1016/j.jacc.2025.02.026</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40204377</guid>
<pubDate>Wed, 09 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Cian P McCarthy</dc:creator>
<dc:creator>John W McEvoy</dc:creator>
<dc:creator>James L Januzzi</dc:creator>
<dc:date>2025-04-09</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Troponin Testing for Cardiovascular Primary Prevention Decision Making?</dc:title>
<dc:identifier>pmid:40204377</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.02.026</dc:identifier>
</item>





























</channel>
</rss>